Finding the Path to Biobank Sustainability Through Sound Business Planning

Biopreservation and Biobanking

Volumn 13, Issue 6, 2015, Pages 385-386

  Henderson, Marianne ^a   Simeon Dubach, Daniel ^b   Albert, Monique ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Medservice   (Switzerland)

^c ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOBANK; CLINICAL RESEARCH; COMMERCIAL PHENOMENA; EDITORIAL; INFORMATION PROCESSING; PLANNING; PRIORITY JOURNAL; STANDARDIZATION; UNITED KINGDOM; UNITED STATES; ECONOMIC MODEL; ECONOMICS; FINANCIAL MANAGEMENT; ORGANIZATION AND MANAGEMENT; PUBLICATION;

BIOLOGICAL SPECIMEN BANKS; FINANCIAL MANAGEMENT; MODELS, ECONOMIC; PERIODICALS AS TOPIC;

EID: 84952782615     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2015.29039.mh     Document Type: Editorial

References (4)

1. Simeon-Dubach D, Henderson MK. Sustainability in biobanking. Biopreserv Biobank 2014;12:287-291.
2. Prinz F, Schlange T, Asadullah K. Believe it or not: How much can we rely on published data on potential drug targets? Nat Rev Drug Discov 2011;10:712.
3. Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature 2012;483:531-533.
4. Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol 2015;13: e1002165.